ADIPOQ and irritable bowel syndrome: In the two publications by Russo et al. [16,17], serum adiponectin levels were significantly higher in patients with IBS-D (especially with normal small-intestinal permeability) in comparison to healthy controls, whereas Baram et al. [20] reported the opposite results in a group including patients with all types of IBS.